Despite a 66% drop from first week sales of 721,000 copies, Coldplay's fourth album Viva la Vida or Death and All His Friends retains the top spot on the Billboard 200, selling 249,000 copies in the album's second week of release. Billboard reported the chart placement Wednesday and noted album sales are down 7.66% in the last week while dropping 13.2% behind the same week totals from one year ago.
The album was released in the United Kingdom three weeks ago tomorrow, while it has only been out in the United States for two weeks. It debuted big in the UK, selling 302,000 copies in the first three days it was out and selling 500,000 copies after ten days. Sales in the U.S. over seven days are obviously larger than the UK figures, pointing to rumored hopes from the band's music label EMI that the album would provide a significant boost for the company during the summer and possibly the year.
I've had the album since it was released, reporting that very day about the packaging of a vinyl and CD copy together that seemed to hint EMI was aware that consumers listen to music more frequently on MP3 players even if they prefer vinyl copies for nostalgia or the entire experience. Two weeks at number is impressive in today's market and even though sales dropped 66%, 249,000 copies is a nice figure for one week. If continued rumors are true that the band will release another album within a year and a half, the future of EMI may be more and more based on the success of one band.
Last updated: February 09, 2010: 09:31 PM
Hot Stocks
DailyFinance Headlines
- Disney Reports Flat Earnings But Sees Conditions Improving
- Google's Bad Buzz: Microsoft, Yahoo Mock New Social Product
- Paulson Predicts U.S. Will Recover 'Every Penny' of Bank Bailout Cash
- The Dow's Jump Doesn't Mean All's Well in Europe
- Hermes Opens Store Just for Men
TheFlyOnTheWall.com Headlines
- Terreno Realty 8.75M share IPO priced at $20.00
- MGP Ingredients, Inc. reports Q2 EPS 28c vs. consensus of 19c
- Zale retains Peter J. Solomon Company to identify opportunities
- EOG Resources increases quarterly dividend 7% to 15.5c per share
- EOG Resources reports Q4 adjusted EPS 92c vs. consensus of 98c
BioHealth Investor Headlines
- Cell Therapeutics Facing Tougher FDA (CTIC)
- New Restless Leg Syndrome Review for XenoPort (XNPT, GSK)
- AMAG Fights Back (AMAG)
- Human Genome Sciences… When Insiders Sell Stock (HGSI)
- 10-Bagger Hunt Heads Back to Repros (RPRX)
WalletPop Headlines
- Borders coupon for 33% off
- No seed shortage for gardeners this spring, despite reports to the contrary
- Deaths spark crib recall: CSPC says to stop using Generation 2 and ChildESIGNS cribs
- Survey says? Homeowners think real estate collapse is over
- Dave Ramsey's recession-themed pick-up lines
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Money
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Dow Jones Industrial Average
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
- Zhu Zhu Pets
- Small Business Checking Account
- Crib Recall


